Renaissance Technologies’s Spero Therapeutics SPRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.41M | Sell |
832,165
-138,742
| -14% | -$402K | ﹤0.01% | 1995 |
|
|
2025
Q1 | $699K | Sell |
970,907
-134,684
| -12% | -$97K | ﹤0.01% | 2602 |
|
|
2024
Q4 | $1.14M | Buy |
1,105,591
+130,938
| +13% | +$135K | ﹤0.01% | 2426 |
|
|
2024
Q3 | $1.31M | Sell |
974,653
-1,299
| -0.1% | -$1.74K | ﹤0.01% | 2294 |
|
|
2024
Q2 | $1.27M | Buy |
975,952
+121,492
| +14% | +$158K | ﹤0.01% | 2183 |
|
|
2024
Q1 | $1.47M | Buy |
854,460
+306,995
| +56% | +$528K | ﹤0.01% | 2237 |
|
|
2023
Q4 | $805K | Buy |
547,465
+300
| +0.1% | +$441 | ﹤0.01% | 2543 |
|
|
2023
Q3 | $662K | Sell |
547,165
-46,266
| -8% | -$56K | ﹤0.01% | 2574 |
|
|
2023
Q2 | $860K | Buy |
593,431
+183,131
| +45% | +$265K | ﹤0.01% | 2561 |
|
|
2023
Q1 | $595K | Buy |
410,300
+67,400
| +20% | +$97.7K | ﹤0.01% | 2790 |
|
|
2022
Q4 | $593K | Buy |
342,900
+128,200
| +60% | +$222K | ﹤0.01% | 2853 |
|
|
2022
Q3 | $429K | Sell |
214,700
-724,317
| -77% | -$1.45M | ﹤0.01% | 3018 |
|
|
2022
Q2 | $696K | Buy |
939,017
+829,917
| +761% | +$615K | ﹤0.01% | 2949 |
|
|
2022
Q1 | $949K | Buy |
+109,100
| New | +$949K | ﹤0.01% | 2762 |
|
|
2020
Q4 | – | Sell |
-153,203
| Closed | -$1.71M | – | 3698 |
|
|
2020
Q3 | $1.71M | Sell |
153,203
-176,700
| -54% | -$1.97M | ﹤0.01% | 2227 |
|
|
2020
Q2 | $4.46M | Buy |
329,903
+5,600
| +2% | +$75.8K | ﹤0.01% | 1718 |
|
|
2020
Q1 | $2.62M | Sell |
324,303
-13,900
| -4% | -$112K | ﹤0.01% | 1913 |
|
|
2019
Q4 | $3.25M | Buy |
338,203
+85,400
| +34% | +$821K | ﹤0.01% | 2091 |
|
|
2019
Q3 | $2.68M | Buy |
252,803
+37,900
| +18% | +$402K | ﹤0.01% | 2121 |
|
|
2019
Q2 | $2.47M | Buy |
214,903
+101,600
| +90% | +$1.17M | ﹤0.01% | 2222 |
|
|
2019
Q1 | $1.45M | Buy |
113,303
+70,400
| +164% | +$902K | ﹤0.01% | 2490 |
|
|
2018
Q4 | $264K | Buy |
42,903
+30,903
| +258% | +$190K | ﹤0.01% | 3071 |
|
|
2018
Q3 | $126K | Buy |
+12,000
| New | +$126K | ﹤0.01% | 3219 |
|